CNN Erin Burnett OutFront May 17, 2013 03:21:00
Years in the project. that investment is paying off. the brock analysis test costs $4,000, often covered by insurance. and made up 82% of the company's revenue in fiscal 2012. the company's profit, $112 million. this biotech analyst has followed myriad for a decade. >> are they going to stop researchers from using their work? no. but the idea is if someone else tries to do what they're doing kplertially, they have to be protected. that's the critical difference. >> reporter: myriad argue that's patented genes encourages innovation and investment and hasn't prevented research. others disagree. ...